Genomic analysis of pediatric SIRS and septic shock
Genomic analysis of pediatric SIRS and septic shock
批准号:
7827547
负责人:
HECTOR R. WONG
金额:
$27.5万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-08-31
关键词:
AdultAnimalsBackBiologicalBiological ProcessBiologyBismuthBloodBlood specimenCalibrationCharacteristicsChildChild health careChildhoodClinicalCohort StudiesCollaborationsContractsCouplingCritical IllnessCritically ill childrenDataDepositionDetectionDevelopmentElectrodesEngineeringEnrollmentEnvironmental ExposureFutureGene Expression ProfilingGenomicsGoalsHeavy MetalsHomeostasisIonsIronLaboratoriesLaboratory StudyLeadLiquid substanceLiteratureManganeseMeasurementMeasuresMetalsMethodsMicrofluidicsOxidative StressPathologyPatientsPerformancePhysiologicalPlayPopulationReaderRecording of previous eventsRecoveryReference StandardsRoleSamplingScanningSeptic ShockSeriesSerumSignal TransductionStressStudy SubjectSupplementationSurvivorsSystemTechnologyTestingTherapeuticTimeTranslational ResearchUniversitiesValidationWhole BloodWound HealingZincbasebiological adaptation to stressblood glucose regulationclinical applicationcohortcommercializationcostfollow-upgene repressionimmune functioninstrumentlarge scale productionmeetingsmicro-total analysis systemparent grantpoint of careprogramspublic health relevanceresearch studyresponsesensorskillsstemvolunteer
中文摘要
描述(由申请人提供):本申请是母授权R 01 GM 064619的竞争性修订,并根据通知# NOT-OD-09-058提交。竞争性修订旨在开发一种用于测量感染性休克儿童血清锌浓度的即时平台,即“锌芯片”。“锌芯片开发的基本原理直接源于上述母基金支持的转化研究计划产生的数据。我们一直在对感染性休克儿童进行基因表达谱研究(微阵列)。一个意想不到的发现是,儿科感染性休克的特点是广泛和持久的抑制基因的功能注释相关的锌生物学。这些数据的功能验证表明,非幸存者的儿科感染性休克有异常低的血清锌浓度相比,幸存者。这些数据表明,改变锌稳态在儿科感染性休克的病理生物学中起作用,这一论断得到了一系列后续临床和实验室研究的支持。因此,我们假设补锌可能是一种有效的治疗策略,在儿科感染性休克,并准备直接测试这一假设进行补锌研究重症儿童感染性休克。以安全和严格的方式进行这些研究的一个重要组成部分是能够可靠和有效地测量这些患者的血清锌浓度。目前用于测量锌的方法是准确的,但昂贵且耗时。因此,我们建议开发一个即时平台,以有效和准确地测量血清锌浓度。锌芯片将与辛辛那提大学工程系合作开发,该工程系在开发临床应用的护理点平台方面有着丰富的历史,包括测量生物液体中重金属的能力。首先使用加标已知浓度锌的供体血清样本检测锌芯片(特定目标1)。在具体目标2中,我们将通过比较锌芯片衍生的测量值与参考实验室数据,测试锌芯片在危重儿童床边的精密度和准确度。我们预计,锌片的成功开发将是安全有效地进行上述锌补充试验的重要进展。这一竞争性修订符合复苏法案的目标,以两种方式刺激经济。在短期内,这将使我们能够与辛辛那提大学工程系合作开发锌芯片,从而获得额外的所需技能。从长远来看,锌片的开发将需要更大规模的生产,因此可能导致商业化。
公共卫生相关性:该计划的交付成果将是开发用于准确和快速测量重症儿童血清锌浓度的即时护理平台,即锌芯片。通过发展以安全和严格的方式进行补锌试验的能力,将对儿童健康产生积极影响。
英文摘要
DESCRIPTION (provided by applicant): This application is a competitive revision of the parent grant R01GM064619 and is being submitted in response to notice # NOT-OD-09-058. The competitive revision seeks to develop a point-of-care platform for measuring serum zinc concentrations in children with septic shock, the "zinc chip." The rationale for development of the zinc chip stems directly from data generated through the translational research program supported by the above parent grant. We have been conducting gene expression profiling studies (microarray) in children with septic shock. An unexpected finding is that pediatric septic shock is characterized by widespread and persistent repression of genes having functional annotations related to zinc biology. Functional validation of these data demonstrated that non-survivors of pediatric septic shock have abnormally low serum zinc concentrations compared to survivors. These data suggest that altered zinc homeostasis plays a role in the pathobiology of pediatric septic shock, and this assertion is well supported by a series of follow-up clinical and laboratory studies. Thus, we hypothesize that zinc supplementation may be an effective therapeutic strategy in pediatric septic shock, and are preparing to directly test this hypothesis by conducting zinc supplementation studies in critically ill children with septic shock. An important component for carrying out these studies in a safe and rigorous manner will be the capability to reliably and efficiently measure serum zinc concentrations in these patients. Current methods for measuring zinc are accurate, but costly and time consuming. Accordingly, we are proposing to develop a point-of-care platform to efficiently and accurately measure serum zinc concentrations. The zinc chip will be developed in collaboration with the University of Cincinnati Department of Engineering, which has a rich history of developing point-of-care platforms for clinical application, including the ability to measure heavy metals in biological fluids. The zinc chip will first be tested using donor serum samples spiked with known concentrations of zinc (Specific Aim 1). In Specific Aim 2 we will test the precision and accuracy of the zinc chip at the bedside of critically ill children by comparing zinc chip-derived measurements with reference laboratory data. We expect that successful development of the zinc chip will be an important advance in the safe and efficient conduct of the aforementioned zinc supplementation trials. This competitive revision meets the goals of the Recovery Act to stimulate the economy in two ways. In the short term, it will allow us to contract for additional needed skills by collaborating with the University of Cincinnati Department of Engineering to develop the zinc chip. In the long-term, development of the zinc chip will require larger scale production and could therefore lead to commercialization.
Public health Relevance: The deliverable of this program will be the development of point-of-care platform for accurate and rapid measurement of serum zinc concentrations in critically ill children, the zinc chip. Child health will be positively impacted by developing the capability of conducting zinc supplementation trials in a safe and rigorous manner.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1097/ccm.0000000000001852
发表时间:
2016-11
期刊:
Critical care medicine
影响因子:
8.8
作者:
[Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, Weiss SL, Fitzgerald J, Checchia PA, Meyer K, Quasney M, Hall M, Gedeit R, Freishtat RJ, Nowak J, Raj SS, Gertz S, Howard K, Harmon K, Lahni P, Frank E, Hart KW, Nguyen TC, Lindsell CJ]
通讯作者:
Lindsell CJ
DOI:
10.1186/cc10537
发表时间:
2012-02-08
期刊:
Critical care (London, England)
影响因子:
--
作者:
[Wong HR]
通讯作者:
Wong HR
DOI:
10.1186/cc11847
发表时间:
2012-10-29
期刊:
Critical care (London, England)
影响因子:
--
作者:
[Wong HR, Cvijanovich NZ, Hall M, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, Checchia PA, Lin R, Bigham MT, Sen A, Nowak J, Quasney M, Henricksen JW, Chopra A, Banschbach S, Beckman E, Harmon K, Lahni P, Shanley TP]
通讯作者:
Shanley TP
DOI:
10.1186/1741-7015-7-34
发表时间:
2009-07-22
期刊:
BMC medicine
影响因子:
9.3
作者:
[Wong HR, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Willson DF, Freishtat RJ, Anas N, Meyer K, Checchia PA, Monaco M, Odom K, Shanley TP]
通讯作者:
Shanley TP
DOI:
10.1586/eri.10.154
发表时间:
2011-01
期刊:
Expert review of anti-infective therapy
影响因子:
5.7
作者:
[Standage SW, Wong HR]
通讯作者:
Wong HR
共 17 条
Sepsis from Bedside to Bench to Bedside
-
批准号:9898384
-
项目类别:
-
资助金额:$50.59万
-
财政年份:2018
-
负责人:HECTOR R. WONG
-
依托单位:
PCSK9 and Pediatric Sepsis-Related MODS
-
批准号:9756433
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2018
-
负责人:HECTOR R. WONG
-
依托单位:
Sepsis from Bedside to Bench to Bedside
-
批准号:10132344
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2018
-
负责人:HECTOR R. WONG
-
依托单位:
Supplement for MIRA award_Wong_2021
-
批准号:10389655
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2018
-
负责人:HECTOR R. WONG
-
依托单位:
Novel diagnostic and stratification tools for septic shock
-
批准号:8841381
-
项目类别:
-
资助金额:$48.95万
-
财政年份:2014
-
负责人:HECTOR R. WONG
-
依托单位:
Novel diagnostic and stratification tools for septic shock
-
批准号:9234036
-
项目类别:
-
资助金额:$48.95万
-
财政年份:2014
-
负责人:HECTOR R. WONG
-
依托单位:
Novel diagnostic and stratification tools for septic shock
-
批准号:8695557
-
项目类别:
-
资助金额:$50.36万
-
财政年份:2014
-
负责人:HECTOR R. WONG
-
依托单位:
Novel diagnostic and stratification tools for septic shock
-
批准号:8970115
-
项目类别:
-
资助金额:$30.07万
-
财政年份:2014
-
负责人:HECTOR R. WONG
-
依托单位:
Stratification of pediatric septic shock
-
批准号:8366660
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2012
-
负责人:HECTOR R. WONG
-
依托单位:
Stratification of pediatric septic shock
-
批准号:8525406
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2012
-
负责人:HECTOR R. WONG
-
依托单位:
Stratification of pediatric septic shock
-
批准号:8697067
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2012
-
负责人:HECTOR R. WONG
-
依托单位:
MMP-8 as a novel therapeutic target in sepsis
-
批准号:8245762
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2011
-
负责人:HECTOR R. WONG
-
依托单位:
MMP-8 as a novel therapeutic target in sepsis
-
批准号:8077606
-
项目类别:
-
资助金额:$29.05万
-
财政年份:2011
-
负责人:HECTOR R. WONG
-
依托单位:
MMP-8 as a novel therapeutic target in sepsis
-
批准号:8634800
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2011
-
负责人:HECTOR R. WONG
-
依托单位:
MMP-8 as a novel therapeutic target in sepsis
-
批准号:8449299
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2011
-
负责人:HECTOR R. WONG
-
依托单位:
THE PEDIATRIC SEPSIS BIOMARKER RISK MODEL
-
批准号:7829817
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:HECTOR R. WONG
-
依托单位:
THE PEDIATRIC SEPSIS BIOMARKER RISK MODEL
-
批准号:7933807
-
项目类别:
-
资助金额:$49.96万
-
财政年份:2009
-
负责人:HECTOR R. WONG
-
依托单位:
Genomic Analysis of Pediatric SIRS
-
批准号:6780998
-
项目类别:
-
资助金额:$53.83万
-
财政年份:2003
-
负责人:HECTOR R. WONG
-
依托单位:
Genomic analysis of pediatric SIRS and septic shock
-
批准号:7488514
-
项目类别:
-
资助金额:$32.86万
-
财政年份:2003
-
负责人:HECTOR R. WONG
-
依托单位:
Genomic Analysis of Pediatric SIRS
-
批准号:6678250
-
项目类别:
-
资助金额:$60.71万
-
财政年份:2003
-
负责人:HECTOR R. WONG
-
依托单位:
海外基金